Adalat and Cranial neuropathy - a phase IV clinical study of FDA data
Cranial neuropathy is reported only by a few people who take Adalat.
The phase IV clinical study analyzes which people take Adalat and have Cranial neuropathy. It is created by eHealthMe based on reports of 20,024 people who have side effects while taking Adalat from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
20,024 people reported to have side effects when taking Adalat.
Among them, 2 people (0.01%) have Cranial neuropathy.
What is Adalat?
Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,317 Adalat users for its effectiveness, alternative drugs and more.
What is Cranial neuropathy?
Cranial neuropathy (nerves in the head become damaged) is found to be associated with 97 drugs and 50 conditions by eHealthMe.
Number of Adalat and Cranial neuropathy reports submitted per year:
Gender of people who have Cranial neuropathy when taking Adalat *:
- female: 0.0 %
- male: 100 %
Age of people who have Cranial neuropathy when taking Adalat *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Adalat *:
- Revlimid: 2 people, 100.00%
- Levothyroxine Sodium: 2 people, 100.00%
- Crestor: 2 people, 100.00%
- Hycodan: 1 person, 50.00%
- Aspirin: 1 person, 50.00%
Common side effects people have besides Cranial neuropathy *:
- Vith Nerve Paralysis: 1 person, 50.00%
- Vith Nerve Disorder: 1 person, 50.00%
- Iiird Nerve Paralysis (totally closed eyelid and a down and out deviation of the eye): 1 person, 50.00%
- Iiird Nerve Disorder: 1 person, 50.00%
- Headache (pain in head): 1 person, 50.00%
- Eyes - Bulging (swelling of eyes): 1 person, 50.00%
- Drug Ineffective: 1 person, 50.00%
- Diplopia (double vision): 1 person, 50.00%
Common conditions people have *:
- Multiple Myeloma (cancer of the plasma cells): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Adalat and have Cranial neuropathy?Check whether Cranial neuropathy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cranial neuropathy and when was it recovered:
Expand to all the drugs that have ingredients of nifedipine:
Alternative drugs to, pros and cons of Adalat:
- Adalat (20,317 reports)
Common Adalat side effects:
- High blood pressure: 1,435 reports
- Fever: 1,079 reports
- Diarrhea: 863 reports
- Hypotension (abnormally low blood pressure): 859 reports
- Pneumonia: 828 reports
- Fatigue (feeling of tiredness): 818 reports
- Weakness: 804 reports
Browse all side effects of Adalat:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cranial neuropathy treatments and more:
- Cranial neuropathy (100 reports)
COVID vaccines that are related to Cranial neuropathy:
- Cranial neuropathy in Moderna COVID Vaccine
- Cranial neuropathy in Pfizer BioNTech Covid Vaccine
- Cranial neuropathy in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Cranial neuropathy:
- Cranial neuropathy (97 drugs)
All the conditions that are associated with Cranial neuropathy:
- Cranial neuropathy (50 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ddavp and Nifedipine drug interaction - 2 seconds ago
- Quinine and Muscle Function Loss - 8 seconds ago
- Escitalopram and Tecentriq drug interaction - 10 seconds ago
- How effective is Motrin for Migraine? - 11 seconds ago
- Carafate and Gelnique drug interaction - 13 seconds ago
- Heparin and Impaired Gastric Emptying - 14 seconds ago
- Ramipril and Bowel Movement Irregularity - 25 seconds ago
- Nitrolingual and Red Blood Cell Count Decreased - 36 seconds ago
- Fosamax and Acute Severe Asthma - 42 seconds ago
- Forteo and Duodenal Polyp - 46 seconds ago